Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
admin
إن بي آر - علوم
15 أغسطس, 2026
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
